Integra Lifesciences Holdings (IART) Consolidated Net Income (2009 - 2026)

Integra Lifesciences Holdings has disclosed Consolidated Net Income across 18 years of filings, most recently posting $4.5 million for Q2 2026.

• In Q2 2026, Consolidated Net Income rose 100.93% year-over-year to $4.5 million; the TTM figure through Jun 2026 stood at -$7.2 million (up 98.55% YoY), while the FY2025 annual figure was -$516.5 million, down 7337.7% from the prior year.
• Consolidated Net Income came in at $4.5 million for Q2 2026 at Integra Lifesciences Holdings, up from -$4.6 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $52.9 million in Q4 2022 to a low of -$484.1 million in Q2 2025.
• Average Consolidated Net Income over 5 years is -$15.3 million, with a median of $4.3 million recorded in 2023.
• Year-over-year, Consolidated Net Income sank 3803.18% in 2025 and surged 100.93% in 2026.
• Over 5 years, Consolidated Net Income stood at $52.9 million in 2022, then slumped by 62.54% to $19.8 million in 2023, then decreased by 2.01% to $19.4 million in 2024, then tumbled by 108.77% to -$1.7 million in 2025, then jumped by 363.03% to $4.5 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $4.5 million in Q2 2026, -$4.6 million in Q1 2026, and -$1.7 million in Q4 2025.